Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents.
Gang NingYi-Ting LiYou-Ming ChenYing ZhangYing-Fu ZengChao-Shuang LinPublished in: Canadian journal of gastroenterology & hepatology (2017)
Our results showed that DAAs treatment attenuated the activation of monocytes and NK cells in CHC patients. Trial registration number is NCT03063723.